AC-201

· TWi Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AC-201, covering 2014-11-18 to 2020-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout [Phase 2]